Prot# TNX-LVO-04: A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction (PH-HFpEF)

Project: Research project

Project Details

StatusActive
Effective start/end date10/12/1810/12/21

Funding

  • Tenax Therapeutics, Inc. (Prot# TNX-LVO-04)